Yosef E. maruvka
Yosef E. maruvka
Assistant professor. Technion.
Verified email at - Homepage
Cited by
Cited by
Next-generation characterization of the cancer cell line encyclopedia
M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ...
Nature 569 (7757), 503-508, 2019
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
AN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ...
Nature medicine 22 (3), 262-269, 2016
Genetic and transcriptional evolution alters cancer cell line drug response
U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ...
Nature 560 (7718), 325-330, 2018
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
K Ohashi, YE Maruvka, F Michor, W Pao
Journal of Clinical Oncology, 2013
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
P Polak, J Kim, LZ Braunstein, R Karlic, NJ Haradhavala, G Tiao, ...
Nature genetics 49 (10), 1476-1486, 2017
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
Polyploidy can drive rapid adaptation in yeast
AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ...
Nature 519 (7543), 349-352, 2015
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair
NJ Haradhvala, P Polak, P Stojanov, KR Covington, E Shinbrot, JM Hess, ...
Cell 164 (3), 538-549, 2016
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
Recurrent and functional regulatory mutations in breast cancer
E Rheinbay, P Parasuraman, J Grimsby, G Tiao, JM Engreitz, J Kim, ...
Nature 547 (7661), 55-60, 2017
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ...
Cell 183 (5), 1436-1456. e31, 2020
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
EM Chan, T Shibue, JM McFarland, B Gaeta, M Ghandi, N Dumont, ...
Nature 568 (7753), 551-556, 2019
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ...
Nature cancer 1 (5), 493-506, 2020
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
NJ Haradhvala, J Kim, YE Maruvka, P Polak, D Rosebrock, D Livitz, ...
Nature communications 9 (1), 1746, 2018
Analysis of somatic microsatellite indels identifies driver events in human tumors
YE Maruvka, KW Mouw, R Karlic, P Parasuraman, A Kamburov, P Polak, ...
Nature biotechnology 35 (10), 951-959, 2017
Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident
LM Morton, DM Karyadi, C Stewart, TI Bogdanova, ET Dawson, ...
Science 372 (6543), eabg2538, 2021
The genomic and immune landscapes of lethal metastatic breast cancer
L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...
Cell reports 27 (9), 2690-2708. e10, 2019
The system can't perform the operation now. Try again later.
Articles 1–20